A research reported that 58.1% (93/160) of the gastric cancer samples were NF1-positive as compared to 94.4% (151/160) of the matched normal tissue samples (p < 0.001) (Liu et al., 2017), which was consistent with our results. This evidence concerns the gene NF1 and gastric cancer.